Natera Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Change-Receivables" stands at -109.63 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 03/31/2023.
Natera Inc's second quarter result of -4.37 Million USD for the item "Change Receivables" represents an increase of 96.39 percent compared to it's first quarter result.
Also, Natera Inc's second quarter result of -4.37 Million USD for the item "Change Receivables" represents a decrease of -148.54 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Natera Inc's second quarter result of -109.63 Million USD for the item "Change Receivables" represents a decrease of -13.90 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -136.34 Million United States Dollars compared to the value the year prior.
The 1 year change is -136.34 Million United States Dollars.
The 3 year change is -57.61 Million United States Dollars.
The 5 year change is -68.14 Million United States Dollars.
The 10 year change is -107.84 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change Receivables | 280,205,508,085.11 |